NEW YORK, NY / ACCESSWIRE / October 14, 2024 / If you suffered a loss on your PDD Holdings Inc. f/k/a Pinduoduo Inc. (NASDAQ:PDD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pdd-holdings-inc-f-k-a-pinduoduo-inc-lawsuit-submission-form?prid=108393&wire=1 or contact Joseph E. Levi, Esq. via email at […]

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / If you suffered a loss on your Stellantis N.V. (NYSE:STLA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/stellantis-lawsuit-submission-form?prid=108398&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / If you suffered a loss on your Verve Therapeutics, Inc. (NASDAQ:VERV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/verve-therapeutics-inc-lawsuit-submission-form?prid=108397&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of First Solar, Inc. ("First Solar, Inc.") (NASDAQ:FSLR) concerning possible violations of federal securities laws. On October 10, 2024, Jefferies analysts pared their expectations for FirstSolar’s upcoming third-quarter results, stating that "[g]oing into 3Q,

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / If you suffered a loss on your Elanco Animal Health Incorporated (NYSE:ELAN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/elanco-animal-health-incorporated-lawsuit-submission-form?prid=108391&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / If you suffered a loss on your Extreme Networks, Inc. (NASDAQ:EXTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/extreme-networks-inc-lawsuit-submission-form?prid=108390&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Toronto-Dominion Bank ("The Toronto-Dominion Bank") (NYSE:TD) concerning possible violations of federal securities laws. On October 10, 2024, TD Bank issued a press release announcing the resolution of the AML investigations into the

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dexcom-inc-lawsuit-submission-form?prid=108388&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)

PTC Therapeutics, Inc.(NASDAQ: PTCT) announced today that the FDA has set a target regulatory action date of July 29, 2025,for the review of the New Drug Application (NDA) for sepiapterin, consistent with a standard review timeline. The NDA was submitted with an indication for the treatment of pediatric and adult patients with phenylketonuria (PKU),including all

Nelnet, Inc.(NYSE: NNI) today announced it will release earnings for the third quarterended September 30, 2024, after the close of theNew York Stock Exchangeon Thursday, November 7, 2024. Upon release, additional earnings information will be available atwww.nelnetinvestors.com. Learn more aboutNelnetatwww.nelnetinc.com. https://c212.net/c/img/favicon.png?sn=LA30308&sd=2024-10-14 View original content:https://www.prnewswire.com/news-releases/nelnet-to-announce-third-quarter-results-302275558.html SOURCE Nelnet, Inc. https://rt.newswire.ca/rt.gif?NewsItemId=LA30308&Transmission_Id=202410141630PR_NEWS_USPR_____LA30308&DateId=20241014 COMTEX_458795039/1005/2024-10-14T16:30:30